Expert Drug Panel Clears Proposal to Amend Licensing Forms for Advanced Biologics, Xenografts Parthika Patel16 July 2025 4:15 PM ISTNew Delhi: The apex advisory body functioning under the Central Drugs Standard Control Organisation (CDSCO), Drugs Consultative Committee (DCC),...
No Eligible Successor: Centre Clarifies DCGI's Contractual Reappointment Farhat Nasim15 July 2025 9:30 PM ISTNew Delhi: Amid an ongoing legal challenge in the Madurai High Court, the Central government has clarified that its decision to reappoint Dr Rajeev...
Do Not Issue Licenses Without New Drug Permission from DCGI, Govt Panel Tells States Farhat Nasim14 July 2025 11:28 PM ISTNew Delhi: In a move to reinforce coordination between central and state drug regulatory bodies, the Drugs Consultative Committee (DCC) has called on...
4 Pharma Firms Lose Licenses Over Pregabalin, Tapentadol Misuse Farhat Nasim13 July 2025 10:00 AM ISTJammu: Cracking down on the illegal sale of habit-forming pharmaceutical drugs, the Jammu and Kashmir Drugs Control Department has cancelled the...
Unreadable Expiry Dates, Generic Mix-Ups: Govt Panel Proposes Forming Sub-Committee on Medicine Labelling Farhat Nasim12 July 2025 8:25 PM ISTNew Delhi: In a move responding directly to widespread consumer grievances, the Drugs Consultative Committee (DCC), a statutory body under the Central...
Tirzepatide Shakes Up Obesity Market as Mounjaro Records Rs 390 Mn Sales in June Farhat Nasim11 July 2025 3:05 PM ISTNew Delhi: In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is quickly...
Liv-333 Violates Liv.52 Trademark, Delhi HC Slaps Rs 20 Lakh Damages on Rajasthan Aushdhalaya for Infringing Himalaya's Brand Farhat Nasim10 July 2025 6:58 PM ISTNew Delhi: The Delhi High Court has upheld a commercial court's judgment restraining Rajasthan Aushdhalaya Pvt Ltd from using "Liv-333" as a...
CDSCO Panel Recommends Phase IV Trial for Acne FDC Gel by Precise Biopharma Parthika Patel9 July 2025 11:37 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs Standard Control Organisation (CDSCO)...
Email From 'Chairman' Costs Pharma Company Rs 1.9 Crore in Cyber Fraud Farhat Nasim8 July 2025 5:54 PM ISTBengaluru: A meticulously executed email spoofing attack has led to a massive financial loss for a pharmaceutical company. The North Division Cyber...
Madras HC Flags Licensing Gap, Says Ayurvedic Imports Must Meet Indian Drug Standards Farhat Nasim7 July 2025 7:42 PM ISTChennai: Observing that "it is necessary for the rule-making authority to modify existing rules, prescribe standards and prepare appropriate forms in...
Govt Panel Proposes Braille Cards, Voice-Enabled QR Codes on Medicine Packs to Aid Visually Impaired Farhat Nasim6 July 2025 11:30 AM ISTNew Delhi: In a move aimed at improving accessibility for the visually impaired, the Drugs Consultative Committee (DCC) has recommended placing the...
Govt Panel Makes This Approval Mandatory For New Drug Licenses Farhat Nasim5 July 2025 4:44 PM ISTNew Delhi: Raising serious regulatory concerns, the apex statutory body under the Central Drugs Standard Control Organisation (CDSCO), the Drugs...
